Discontinued — last reported Q3 '23
Archer Daniels Midland Equity Method Investments increased by 4.3% to $5.80B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 15.5%, from $5.02B to $5.80B. Over 5 years (FY 2020 to FY 2025), Equity Method Investments shows an upward trend with a 2.5% CAGR.
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
These are investments in entities where the company exercises significant influence but does not have full control. The...
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
equity_method_investments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.11B | $5.15B | $5.29B | $5.40B | $5.46B | $5.43B | $5.47B | $5.53B | $5.67B | $5.47B | $5.50B | $5.57B | $5.56B | $5.14B | $5.28B | $5.02B | $5.18B | $5.21B | $5.56B | $5.80B |
| QoQ Change | — | +0.7% | +2.7% | +2.3% | +1.1% | -0.6% | +0.7% | +1.1% | +2.5% | -3.5% | +0.6% | +1.2% | -0.2% | -7.5% | +2.6% | -4.8% | +3.0% | +0.6% | +6.8% | +4.3% |
| YoY Change | — | — | — | — | +6.9% | +5.5% | +3.4% | +2.2% | +3.7% | +0.7% | +0.6% | +0.7% | -1.9% | -6.0% | -4.1% | -9.8% | -6.9% | +1.2% | +5.4% | +15.5% |
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Ag Services and Oilseeds | $5.56B | $5.14B | $5.28B | $5.02B | $5.18B | $5.21B | $5.56B | $5.80B |
| Carbohydrate Solutions | $5.56B | $5.14B | $5.28B | $5.02B | $5.18B | $5.21B | $5.56B | $5.80B |
| Nutrition | $5.56B | $5.14B | $5.28B | $5.02B | $5.18B | $5.21B | $5.56B | $5.80B |
| Total | $5.56B | $5.14B | $5.28B | $5.02B | $5.18B | $5.21B | $5.56B | $5.80B |